CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection.
about
Enteroendocrine cells: neglected players in gastrointestinal disorders?An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered MicrobiomeStem Cells in the Intestine: Possible Roles in Pathogenesis of Irritable Bowel SyndromeInflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory diseaseInterleukin 13 and serotonin: linking the immune and endocrine systems in murine models of intestinal inflammationRegulation of the serotonin transporter in the pathogenesis of irritable bowel syndromeSerotonin and GI Disorders: An Update on Clinical and Experimental Studies.Adaptive immunity alters distinct host feeding pathways during nematode induced inflammation, a novel mechanism in parasite expulsion.Gut hormones: emerging role in immune activation and inflammation.Serotonin activates dendritic cell function in the context of gut inflammation.Gastrointestinal viral load and enteroendocrine cell number are associated with altered survival in HIV-1 infected individuals.Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndromeSubjective food hypersensitivity: assessment of enterochromaffin cell markers in blood and gut lavage fluid.JCM-16021, a Chinese Herbal Formula, Attenuated Visceral Hyperalgesia in TNBS-Induced Postinflammatory Irritable Bowel Syndrome through Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in RatsIBS and IBD - separate entities or on a spectrum?Treatment with novel AP-1 and NF-κB inhibitors restores the colonic endocrine cells to normal levels in rats with DSS-induced colitis.5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cellsEffects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitisPhysiological changes in the gastrointestinal tract and host protective immunity: learning from the mouse-Trichinella spiralis model.Association of TNFSF15 polymorphism with irritable bowel syndrome.Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats.Abnormalities in endocrine and immune cells are correlated in dextran‑sulfate‑sodium‑induced colitis in rats.Classification and functions of enteroendocrine cells of the lower gastrointestinal tract.Neuroanatomy of lower gastrointestinal pain disordersMetabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders.Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.5-HT7 receptor signaling: improved therapeutic strategy in gut disordersThe Anti-Inflammatory Effect of Guchangzhixie-Pill by Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in an Ulcerative Colitis Rat Model.Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.Discovery and characterization of a novel tryptophan hydroxylase 1 inhibitor as a prodrug.The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome.IL-13-mediated immunological control of enterochromaffin cell hyperplasia and serotonin production in the gut.Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity.IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease.5-HT3 receptors promote colonic inflammation via activation of substance P/neurokinin-1 receptors in dextran sulphate sodium-induced murine colitis.Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract.Mechanisms underlying gut dysfunction in a murine model of chronic parasitic infection.Enteroendocrine cells in terminal ileal Crohn's disease.Blocking peripheral serotonin synthesis by telotristat etiprate (LX1032/LX1606) reduces severity of both chemical- and infection-induced intestinal inflammation.
P2860
Q24629026-83D9941F-5163-472E-9DA4-30AA36578D43Q24630575-2344F369-A2AF-4B6C-AFC3-E9C8D97B2A8BQ26749356-B5D1EB1D-98AC-4AD1-B7A4-19523BEF7C74Q26752511-94A958B2-36EF-4C61-8EA8-DBFBDA159FF9Q26778350-E6726795-A0EE-469A-88DF-4763A791F15DQ27308772-D8445374-486A-45D5-B2D5-9A85B820CFE2Q28072085-CF61D503-6F46-4CF6-A304-28D4F851862FQ34317503-CEF0C15E-36ED-40EB-8A26-6A8F50F01400Q34561893-3C196B28-8543-4FEF-B21B-9C99C227402CQ34618925-0AF7DC74-4915-4D78-AFFE-6601A2F55366Q34756256-AF863ABC-37B7-49DE-99AA-08E820FF7849Q35022558-113E0956-CFD5-4282-A789-50A845AB45A6Q35061903-F5D93761-C5BE-420C-9B7C-C5D4EE3776C0Q35178813-D222A26F-084D-4541-926F-F6CAC7B55971Q36036768-5F5455D4-BAE8-4A46-A728-A4129C5F4842Q36144375-69D0FC67-0803-4AFD-825A-590361B43049Q36630692-73609375-A552-48F4-A06D-ABE3687284ABQ36681766-7DCC593A-6112-4CBF-9AC2-B4A6E1B5E442Q37083066-882315F6-4DAA-4448-8CFA-FED5BCB96592Q37172041-977535A1-16FC-4C61-8E5D-282797A19F99Q37580090-4DDB462C-3530-496F-8227-34F5D717EC9AQ37707717-38D7725B-6EA5-4D8A-9087-82A11F9C4D91Q37707732-F7A58F9E-37F1-4BDE-A920-AE082626C655Q37868714-CFEE028E-4ECD-4829-9AF0-30DB0738AFA7Q38191576-C818564B-449B-4AB4-BA04-908E4FAE7857Q38219316-1D43CDCF-2CCC-42FF-A169-C9CBA042765FQ38275041-17E34FF4-5698-499E-AA57-7687293FA313Q38310117-0EA1A163-2E5F-490C-8424-A657B46E3AA4Q38606277-446E5306-01D8-4F07-9534-0F2C56867168Q38622923-EC992D89-6638-4011-AD4C-B6A88B3373CDQ38674006-F2321E62-C2AE-40CD-B540-3ACA255AD3FDQ39031805-FA2E7691-F2C9-45CF-9D65-732F2337F819Q39319686-9C888A2A-7D45-4483-AD93-D05353BD2062Q40074896-9C20DC17-0EA8-47BB-9071-BE5138C56B9CQ40147698-A59C1A85-1221-4668-BEE1-B109F737FD36Q42244233-1818C28A-8535-4921-B5BF-1E4A1C58AD7FQ42463124-3ED7383E-D658-4E58-B7A1-72ABBDE3C299Q42877922-A6057068-20D6-4135-8185-F33D56D20648Q48625003-9E43EBEB-9A9D-4752-9E46-A1FEBE41D172Q50952188-620D9C11-99EF-45D2-A9AB-A98AEE8DC146
P2860
CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
CD4+ T cell-mediated immunolog ...... oduction in enteric infection.
@ast
CD4+ T cell-mediated immunolog ...... oduction in enteric infection.
@en
CD4+ T cell-mediated immunolog ...... oduction in enteric infection.
@nl
type
label
CD4+ T cell-mediated immunolog ...... oduction in enteric infection.
@ast
CD4+ T cell-mediated immunolog ...... oduction in enteric infection.
@en
CD4+ T cell-mediated immunolog ...... oduction in enteric infection.
@nl
prefLabel
CD4+ T cell-mediated immunolog ...... oduction in enteric infection.
@ast
CD4+ T cell-mediated immunolog ...... oduction in enteric infection.
@en
CD4+ T cell-mediated immunolog ...... oduction in enteric infection.
@nl
P2093
P2860
P356
P1433
P1476
CD4+ T cell-mediated immunolog ...... oduction in enteric infection.
@en
P2093
Huaqing Wang
Justin Steeds
Monica Verma-Gandhu
Rami T El-Sharkawy
Richard K Grencis
Waliul I Khan
Yasuaki Motomura
Yikang Deng
P2860
P304
P356
10.1136/GUT.2006.103226
P407
P577
2007-02-15T00:00:00Z